185 related articles for article (PubMed ID: 25600225)
1. Mst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosis.
Lee GJ; Yan L; Vatner DE; Vatner SF
Basic Res Cardiol; 2015 Mar; 110(2):7. PubMed ID: 25600225
[TBL] [Abstract][Full Text] [Related]
2. Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.
Yan L; Vatner SF; Vatner DE
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1521-8. PubMed ID: 25193472
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
4. Ataxia telangiectasia mutated kinase plays a protective role in β-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling.
Foster CR; Singh M; Subramanian V; Singh K
Mol Cell Biochem; 2011 Jul; 353(1-2):13-22. PubMed ID: 21404020
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor.
Peter PS; Brady JE; Yan L; Chen W; Engelhardt S; Wang Y; Sadoshima J; Vatner SF; Vatner DE
J Clin Invest; 2007 May; 117(5):1335-43. PubMed ID: 17446930
[TBL] [Abstract][Full Text] [Related]
6. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.
Yamamoto S; Yang G; Zablocki D; Liu J; Hong C; Kim SJ; Soler S; Odashima M; Thaisz J; Yehia G; Molina CA; Yatani A; Vatner DE; Vatner SF; Sadoshima J
J Clin Invest; 2003 May; 111(10):1463-74. PubMed ID: 12750396
[TBL] [Abstract][Full Text] [Related]
7. Injection of wild type embryonic stem cells into Mst1 transgenic blastocysts prevents adult-onset cardiomyopathy.
Zhao Q; Beck AJ; Vitale JM; Schneider JS; Chang C; Gao S; del Re D; Bhaumik M; Yehia G; Sadoshima J; Fraidenraich D
Stem Cell Rev Rep; 2011 Jun; 7(2):326-30. PubMed ID: 21086068
[TBL] [Abstract][Full Text] [Related]
8. Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1.
Hu J; Zhang L; Yang Y; Guo Y; Fan Y; Zhang M; Man W; Gao E; Hu W; Reiter RJ; Wang H; Sun D
J Pineal Res; 2017 Jan; 62(1):. PubMed ID: 27696525
[TBL] [Abstract][Full Text] [Related]
9. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
[TBL] [Abstract][Full Text] [Related]
10. Differential cardiotoxic/cardioprotective effects of beta-adrenergic receptor subtypes in myocytes and fibroblasts in doxorubicin cardiomyopathy.
Fajardo G; Zhao M; Powers J; Bernstein D
J Mol Cell Cardiol; 2006 Mar; 40(3):375-83. PubMed ID: 16458323
[TBL] [Abstract][Full Text] [Related]
11. Beta1 integrins modulate beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling.
Krishnamurthy P; Subramanian V; Singh M; Singh K
Hypertension; 2007 Apr; 49(4):865-72. PubMed ID: 17283249
[TBL] [Abstract][Full Text] [Related]
12. beta2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle.
Burniston JG; Tan LB; Goldspink DF
J Appl Physiol (1985); 2005 Apr; 98(4):1379-86. PubMed ID: 15591297
[TBL] [Abstract][Full Text] [Related]
13. Exosomal Mst1 transfer from cardiac microvascular endothelial cells to cardiomyocytes deteriorates diabetic cardiomyopathy.
Hu J; Wang S; Xiong Z; Cheng Z; Yang Z; Lin J; Wang T; Feng X; Gao E; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3639-3649. PubMed ID: 30251683
[TBL] [Abstract][Full Text] [Related]
14. NF2 signaling pathway plays a pro-apoptotic role in β-adrenergic receptor stimulated cardiac myocyte apoptosis.
Dalal S; Connelly B; Singh M; Singh K
PLoS One; 2018; 13(4):e0196626. PubMed ID: 29709009
[TBL] [Abstract][Full Text] [Related]
15. MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation.
Schirone L; Vecchio D; Valenti V; Forte M; Relucenti M; Angelini A; Zaglia T; Schiavon S; D'Ambrosio L; Sarto G; Stanzione R; Mangione E; Miglietta S; Di Bona A; Fedrigo M; Ghigo A; Versaci F; Petrozza V; Marchitti S; Rubattu S; Volpe M; Sadoshima J; Frati L; Frati G; Sciarretta S
Cell Mol Life Sci; 2023 Aug; 80(9):245. PubMed ID: 37566283
[TBL] [Abstract][Full Text] [Related]
16. Lats2 is a negative regulator of myocyte size in the heart.
Matsui Y; Nakano N; Shao D; Gao S; Luo W; Hong C; Zhai P; Holle E; Yu X; Yabuta N; Tao W; Wagner T; Nojima H; Sadoshima J
Circ Res; 2008 Nov; 103(11):1309-18. PubMed ID: 18927464
[TBL] [Abstract][Full Text] [Related]
17. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
[TBL] [Abstract][Full Text] [Related]
18. Adrenergic regulation of cardiac myocyte apoptosis.
Singh K; Xiao L; Remondino A; Sawyer DB; Colucci WS
J Cell Physiol; 2001 Dec; 189(3):257-65. PubMed ID: 11748583
[TBL] [Abstract][Full Text] [Related]
19. Microsomal Prostaglandin E
Ji S; Guo R; Wang J; Qian L; Liu M; Xu H; Zhang J; Guan Y; Yang G; Chen L
J Pharmacol Exp Ther; 2020 Oct; 375(1):40-48. PubMed ID: 32759273
[TBL] [Abstract][Full Text] [Related]
20. Cardiac-specific Mst1 deficiency inhibits ROS-mediated JNK signalling to alleviate Ang II-induced cardiomyocyte apoptosis.
Cheng Z; Zhang M; Hu J; Lin J; Feng X; Wang S; Wang T; Gao E; Wang H; Sun D
J Cell Mol Med; 2019 Jan; 23(1):543-555. PubMed ID: 30338935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
